| Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus … GR Corey, M Wilcox, GH Talbot, H David Friedland, T Baculik, ... Clinical Infectious Diseases 51 (6), 641-650, 2010 | 282 | 2010 |
| Regional Trends in Antimicrobial Resistance among Clinical Isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the … C Thornsberry, DF Sahm, LJ Kelly, IA Critchley, ME Jones, AT Evangelista, ... Clinical Infectious Diseases 34 (Supplement_1), S4-S16, 2002 | 272 | 2002 |
| Integrated analysis of FOCUS 1 and FOCUS 2: randomized, doubled-blinded, multicenter phase 3 trials of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in … TM File Jr, DE Low, PB Eckburg, GH Talbot, HD Friedland, J Lee, ... Clinical infectious diseases 51 (12), 1395-1405, 2010 | 246 | 2010 |
| FOCUS 1: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia TM File Jr, DE Low, PB Eckburg, GH Talbot, HD Friedland, J Lee, ... Journal of antimicrobial chemotherapy 66 (suppl_3), iii19-iii32, 2011 | 224 | 2011 |
| FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia DE Low, TM File Jr, PB Eckburg, GH Talbot, H David Friedland, J Lee, ... Journal of antimicrobial chemotherapy 66 (suppl_3), iii33-iii44, 2011 | 220 | 2011 |
| Effect of antibiotics on non-growing planktonic cells and biofilms of Escherichia coli MJ Ashby, JE Neale, SJ Knott, IA Critchley Journal of Antimicrobial Chemotherapy 33 (3), 443-452, 1994 | 210 | 1994 |
| The effects of adherence to silicone surfaces on antibiotic susceptibility in Staphylococcus aureus I Williams, WA Venables, D Lloyd, F Paul, I Critchley Microbiology 143 (7), 2407-2413, 1997 | 203 | 1997 |
| Factors Associated with Relative Rates of Antimicrobial Resistance among Streptococcus pneumoniae in the United States: Results from the TRUST Surveillance … JA Karlowsky, C Thornsberry, ME Jones, AT Evangelista, IA Critchley, ... Clinical Infectious Diseases 36 (8), 963-970, 2003 | 201 | 2003 |
| Isolation and Partial Characterization of an Adhesin from Candida albicans IA Critchley, LJ Douglas Microbiology 133 (3), 629-636, 1987 | 189 | 1987 |
| Role of Glycosides as Epithelial Cell Receptors for Candida albicans IA Critchley, LJ Douglas Microbiology 133 (3), 637-643, 1987 | 163 | 1987 |
| Need for Annual Surveillance of Antimicrobial Resistance in Streptococcus pneumoniae in the United States: 2-Year Longitudinal Analysis DF Sahm, JA Karlowsky, LJ Kelly, IA Critchley, ME Jones, C Thornsberry, ... Antimicrobial Agents and Chemotherapy 45 (4), 1037-1042, 2001 | 158 | 2001 |
| The burden of antimicrobial resistance among urinary tract isolates of Escherichia coli in the United States in 2017 IA Critchley, N Cotroneo, MJ Pucci, R Mendes PloS one 14 (12), e0220265, 2019 | 154 | 2019 |
| Activity of daptomycin against susceptible and multidrug-resistant Gram-positive pathogens collected in the SECURE study (Europe) during 2000–2001 IA Critchley, DC Draghi, DF Sahm, C Thornsberry, ME Jones, ... Journal of Antimicrobial Chemotherapy 51 (3), 639-649, 2003 | 154 | 2003 |
| Ceftaroline fosamil: a novel broad-spectrum cephalosporin with expanded anti-Gram-positive activity D Biek, IA Critchley, TA Riccobene, DA Thye Journal of antimicrobial chemotherapy 65 (suppl_4), iv9-iv16, 2010 | 140 | 2010 |
| Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000: TRUST and TSN data for the United States JA Karlowsky, LJ Kelly, C Thornsberry, ME Jones, AT Evangelista, ... International journal of antimicrobial agents 19 (1), 21-31, 2002 | 140 | 2002 |
| Prevalence of antimicrobial resistance among urinary tract pathogens isolated from female outpatients across the US in 1999 JA Karlowsky, ME Jones, C Thornsberry, I Critchley, LJ Kelly, DF Sahm International journal of antimicrobial agents 18 (2), 121-127, 2001 | 139 | 2001 |
| Evaluation of current activities of fluoroquinolones against gram-negative bacilli using centralized in vitro testing and electronic surveillance DF Sahm, IA Critchley, LJ Kelly, JA Karlowsky, DC Mayfield, ... Antimicrobial agents and chemotherapy 45 (1), 267-274, 2001 | 126 | 2001 |
| In vitro activity of levofloxacin against contemporary clinical isolates of Legionella pneumophila, Mycoplasma pneumoniae and Chlamydia pneumoniae from North America and Europe IA Critchley, ME Jones, PD Heinze, D Hubbard, HD Engler, ... Clinical Microbiology and Infection 8 (4), 214-221, 2002 | 122 | 2002 |
| Aminoacyl-tRNA synthetases: essential and still promising targets for new anti-infective agents UA Ochsner, X Sun, T Jarvis, I Critchley, N Janjic Expert opinion on investigational drugs 16 (5), 573-593, 2007 | 119 | 2007 |
| National and regional assessment of antimicrobial resistance among community-acquired respiratory tract pathogens identified in a 2005-2006 US Faropenem surveillance study IA Critchley, SD Brown, MM Traczewski, GS Tillotson, N Janjic Antimicrobial agents and chemotherapy 51 (12), 4382-4389, 2007 | 113 | 2007 |
